The EU is facing a growing drug crisis, with increasing accessibility and potency of substances, leading to a rise in overdose deaths. In response, the EU has launched a new Drugs Strategy focusing on preparedness, public health, security, harm prevention, and international cooperation. However, critics argue that the strategy may prioritize enforcement over harm reduction, potentially shifting trafficking activities rather than eliminating them.